Cognex Corporation
NASDAQ:CGNXHardware, Equipment & Parts
-$0.64 today
- Market cap
- $8.27B
- Beta
- 1.51
- P/E (TTM)
- 75.7
- EPS (TTM)
- $0.86
- Dividend yield
- 0.52%
Volume 1.61M
Average 2.14M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Cognex Corporation
NASDAQ:CGNX
Intrinsic Alpha fair value
Locked
Current Price
$49.13
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -17.9% | +39.3% (5yr)5 analysts |
| Revenue | N/A | N/A | -0.4% | +13.7% (5yr)14 analysts |
| Net Income | N/A | N/A | -19.0% | +39.5% (5yr)14 analysts |
| EBIT | N/A | N/A | -12.9% | +35.9% (5yr)14 analysts |
Analysis
Recent growth has been strongest in Revenue at -0.4% over three years. Forward estimates point to Net Income at +39.5% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Zebra Technologies Corporation NASDAQ:ZBRA | $15.26B | $324.00 | Fairly Valued | 28.1 | +38.42% |
Sensata Technologies Holding plc NYSE:ST | $5.61B | $38.56 | Undervalued | 152.7 | +30.94% |
Novanta Inc. NASDAQ:NOVT | $4.50B | $118.88 | Overvalued | 116.5 | +18.42% |
MicroVision, Inc. NASDAQ:MVIS | $35.75M | $1.05 | Not rated | -1.2 | +136.93% |
Continue the stock analysis
Jump to another research area for this company.